Efficacy and Safety of Lenalidomide, Anti-PD-1 Antibody Combined with Orelabrutinib or Rituximab in the Treatment of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
| Autor: | Qing, Miao *, Huang, Yongfen *, Chen, Can *, Wang, Lingling *, Feng, Jun *, Xu, Chuanhai *, Cheng, Yuexin *, Dong, Jianming *, Zhang, Linlin *, Xu, Hao * |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:3769-3770 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|